Fanconi Anemia Cancer Cell Repository
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- OHSU Knight Cancer Institute
- Enrollment
- 8
- Locations
- 1
- Primary Endpoint
- Creation of a Fanconi Anemia Cell Repository using rare solid tumor samples from patients with Fanconi anemia
Study Overview
Brief Summary
RATIONALE: Collecting and storing samples of tumor tissue from patients with Fanconi anemia to test in the laboratory may help the study of cancer in the future.
PURPOSE: This laboratory study is collecting and storing tumor tissue samples from patients with Fanconi anemia.
Detailed Description
OBJECTIVES:
- Acquire rare solid tumor samples from patients with Fanconi anemia in order to create a Fanconi Anemia Cell Repository at the Oregon Health and Science University Cancer Institute.
- Study repository tissue using a variety of molecular methods, including gene microarrays.
- Develop cancer cell lines that are publicly available from tissue archived from patients with Fanconi anemia.
OUTLINE: Tumor biopsies are collected from patients with Fanconi anemia and archived for future molecular studies, cell line generation, and general usage by the research community at large. Medical information about the patient's cancer is also archived.
PROJECTED ACCRUAL: Not specified.
Study Design
- Study Type
- Observational
- Observational Model
- Case Control
- Time Perspective
- Retrospective
Eligibility Criteria
- Ages
- 1 Year to 55 Years (Child, Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Creation of a Fanconi Anemia Cell Repository using rare solid tumor samples from patients with Fanconi anemia
Time Frame: Duration of the study
Study tissue samples by molecular methods, including gene microarrays
Time Frame: Duration of the study
Development of cancer cell lines from tissue archived from patients with Fanconi anemia
Time Frame: Duration of the study
Secondary Outcomes
No secondary outcomes reported
Investigators
Grover Bagby
Professor Emeritus
OHSU Knight Cancer Institute
